Classes
- All Drugs
- Allergy/Cold/ENT
- Anesthesia/Pain Management
- Asthma/Pulmonary
- Cardiovascular
- Dental/Oral Care
- Dermatologic
- Diagnostic
- Emergency
- Endocrine/Metabolism
- Gastrointestinal
- Hematology/Oncology
- Immunizations
- Immunology
- Infectious Disease
- Nephrology/Urology
- Neurologic
- Nutrition/Electrolytes
- Obstetrics/Gynecology
- Ophthalmic
- Psychiatric
- Rheumatologic
Hematology/ Oncology
Subclasses
- Adrenolytic Agents, Oncologic
- Alkylating Agents, Alkyl Sulfonates
- Alkylating Agents, Ethyleneimines
- Alkylating Agents, Methylhydrazines
- Alkylating Agents, Nitrogen Mustards
- Alkylating Agents, Nitrosoureas
- Alkylating Agents, Platinum Analogs
- Alkylating Agents, Tetrahydroisoquinolines
- Alkylating Agents, Triazenes
- Anthracyclines
- Anti-von Willebrand Factors
- Antibiotic Oncologics
- Antiemetics, 2nd Generation Antipsychotics
- Antiemetics, Anticholinergics
- Antiemetics, Benzodiazepines
- Antiemetics, Cannabinoids
- Antiemetics, Corticosteroids
- Antiemetics, Dopamine Antagonists
- Antiemetics, Neurokinin-1 Receptor Antagonists
- Antiemetics, Phenothiazines
- Antiemetics, Serotonin (5-HT3) Receptor Antagonists
- Antimetabolites, Folate Analogs
- Antimetabolites, Purine Analogs
- Antimetabolites, Pyrimidine Analogs
- Antimetabolites, Urea Derivatives
- Antineoplastics, Topical
- Antiplatelets, Hematologic
- Asparaginase Enzymes
- BCL-2 Inhibitors
- Bisphosphonates, Oncologic
- Cereblon E3 Ligase Modulators
- Chemokine Receptor Antagonists, Hematologic
- Colony Stimulating Factors (CSFs)
- Complement Inhibitors, Hematologic
- Corticosteroids, Oncologic
- Cytidine Deaminase Inhibitors
- Diagnostic Agents, Oncologic
- Differentiating Agents
- Dopamine Antagonists, Oncologic
- EGFR Antagonists
- Epigenetic Modifiers, DNA Methylation Inhibitors
- Epigenetic Modifiers, Histone Deacetylase (HDAC) Inhibitors
- Epigenetic Modifiers, Histone Methyltransferase (HMT) Inhibitors
- Epigenetic Modifiers, Isocitrate Dehydrogenase (IDH) Inhibitors
- Erythroid Maturation Agents
- Erythropoiesis-Stimulating Agents (ESAs)
- FGF23 Inhibitors
- Fibrinolytics, Hematologic
- Folate Derivatives
- Gamma Secretase Inhibitors
- Gene Therapy, Hemoglobin Disorders
- Gene Therapy, Interferons
- Glucocorticoid Receptor Antagonists
- Graft Versus Host Disease
- Hedgehog Pathway Inhibitors
- Hematopoietic Stem Cell Mobilizers
- Hemostasis: Anti-Tissue Factor Pathway Inhibitors (TFPIs)
- Hemostasis: Antithrombin Small Interfering Ribonucleic Acids (siRNAs)
- Hemostasis: Coagulation Factors/ Cofactors
- Hemostasis: Fibrinolysis Inhibitors
- Hemostasis: Gene Therapy, Coagulation Factors
- Hemostasis: Vasopressin Analogs
- Hepcidin Mimetics
- HER2 Antagonists
- Hormonal Oncologics, Androgens
- Hormonal Oncologics, Antiandrogens
- Hormonal Oncologics, Antiestrogens
- Hormonal Oncologics, Estrogens
- Hormonal Oncologics, GnRH Analogs
- Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)
- Hypoxia-Inducible Factor-2 Alpha (HIF-2a) Inhibitors
- Immunomodulatory IMiDs
- Immunotherapy, Anti-GD2
- Immunotherapy, Anti-MAGE-A4
- Immunotherapy, Antibody-Drug Conjugates
- Immunotherapy, BCMA Inhibitors
- Immunotherapy, Bispecific CD3 T-Cell Engagers
- Immunotherapy, CAR T-Cells
- Immunotherapy, CCR4 Inhibitors
- Immunotherapy, CD123 Inhibitors
- Immunotherapy, CD19 Inhibitors
- Immunotherapy, CD20 Inhibitors
- Immunotherapy, CD22 Inhibitors
- Immunotherapy, CD30 Inhibitors
- Immunotherapy, CD33 Inhibitors
- Immunotherapy, CD38 Inhibitors
- Immunotherapy, CD52 Inhibitors
- Immunotherapy, CD79 Inhibitors
- Immunotherapy, Claudin 18.2 (CLDN18.2) Inhibitors
- Immunotherapy, CTLA-4 Inhibitors
- Immunotherapy, DLL3 Inhibitors
- Immunotherapy, EGFR Inhibitors
- Immunotherapy, Folate Receptor Alpha Inhibitors
- Immunotherapy, gp100 Peptide/ HLA Inhibitors
- Immunotherapy, GPRC5D Inhibitors
- Immunotherapy, HER2 Inhibitors
- Immunotherapy, HER3 Inhibitors
- Immunotherapy, Immune Checkpoint Inhibitors
- Immunotherapy, Interferons
- Immunotherapy, Interleukin Inhibitors
- Immunotherapy, Interleukin-15
- Immunotherapy, Interleukin-2
- Immunotherapy, LAG-3 Inhibitors
- Immunotherapy, MET Inhibitors
- Immunotherapy, Nectin-4 Inhibitors
- Immunotherapy, PD-1/ PD-L1 Inhibitors
- Immunotherapy, Post-Transplant Lymphoproliferative Disease
- Immunotherapy, SLAMF7 Inhibitors
- Immunotherapy, Therapeutic Cancer Vaccines
- Immunotherapy, Tissue Factor Inhibitors
- Immunotherapy, TROP-2 Inhibitors
- Immunotherapy, Tumor Infiltrating Lymphocyte (TIL) Therapy
- Immunotherapy, VEGF Inhibitors
- Interferon Antagonists
- Iron Homeostasis
- Kinase Inhibitors, Activin A Receptor Type I (ACVR1) Inhibitors
- Kinase Inhibitors, AKT Inhibitors
- Kinase Inhibitors, ALK Inhibitors
- Kinase Inhibitors, BCR-ABL Inhibitors
- Kinase Inhibitors, BRAF Inhibitors
- Kinase Inhibitors, BTK Inhibitors
- Kinase Inhibitors, CDK Inhibitors
- Kinase Inhibitors, CK1 Inhibitors
- Kinase Inhibitors, CSF1R Inhibitors
- Kinase Inhibitors, EGFR Inhibitors
- Kinase Inhibitors, FAK Inhibitors
- Kinase Inhibitors, FGFR Inhibitors
- Kinase Inhibitors, FLT3 Inhibitors
- Kinase Inhibitors, HER2 Inhibitors
- Kinase Inhibitors, JAK Inhibitors
- Kinase Inhibitors, KIT Inhibitors
- Kinase Inhibitors, MEK Inhibitors
- Kinase Inhibitors, MET Inhibitors
- Kinase Inhibitors, mTOR Inhibitors
- Kinase Inhibitors, PDGFRA inhibitors
- Kinase Inhibitors, PI3K Inhibitors
- Kinase Inhibitors, RET Inhibitors
- Kinase Inhibitors, ROS1 Inhibitors
- Kinase Inhibitors, SYK Inhibitors
- Kinase Inhibitors, TAM Inhibitors
- Kinase Inhibitors, TRK Inhibitors
- Kinase Inhibitors, Type II RAF Inhibitors
- Kinase Inhibitors, VEGF Inhibitors
- KRAS Inhibitors
- Menin Inhibitors
- Mitosis Inhibitors, Antimicrotubule Agents
- Mitosis Inhibitors, Taxanes
- Mitosis Inhibitors, Topoisomerase I Inhibitors
- Mitosis Inhibitors, Topoisomerase II Inhibitors
- Mitosis Inhibitors, Vinca Alkaloids
- Nuclear Export Inhibitors
- Ornithine Decarboxylase Inhibitors
- PARP Inhibitors
- Photodynamic Agents, Oncologic
- Porphyria
- Protease Activators
- Proteasome Inhibitors
- Protein Synthesis Inhibitors, Cephalotaxines
- Protein Synthesis Inhibitors, Exotoxins
- Pyruvate Kinase Activators
- Radiopharmaceuticals, Oncologic
- RANKL Inhibitors, Oncologic
- Sclerosing Agents, Pulmonary
- Sickle Cell Disease
- Stem Cell Therapy
- Supportive Care: Cardiotoxicity
- Supportive Care: Extravasation
- Supportive Care: Folate Analog Toxicity
- Supportive Care: Hemorrhagic Cystitis
- Supportive Care: Hyperuricemia
- Supportive Care: Mucositis
- Supportive Care: Myelosuppression
- Supportive Care: Nephrotoxicity
- Supportive Care: Ototoxicity
- Supportive Care: Pyrimidine Analog Toxicity
- Supportive Care: Xerostomia
- Telomerase Inhibitors
- Thalassemia
- Thrombopoietin Receptor Agonists
- VEGF Antagonists
Bisphosphonates, Oncologic |
|
|
|---|---|---|
Drug Names |
Generic Names |
|
| Aredia | pamidronate | |
| pamidronate | generic | |
| zoledronic acid 4 mg injection | generic | |
| Zometa | zoledronic acid 4 mg injection |